Literature DB >> 32295922

Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.

Chi-You Chang1, Helene Minyi Liu2, Ming-Fu Chang3, Shin C Chang4.   

Abstract

Type I and type III interferons (IFNs) are the frontline of antiviral defense mechanisms that trigger hundreds of downstream antiviral genes. In this study, we observed that MERS-CoV nucleocapsid (N) protein suppresses type I and type III IFN gene expression. The N protein suppresses Sendai virus-induced IFN-β and IFN-λ1 by reducing their promoter activity and mRNA levels, as well as downstream IFN-stimulated genes (ISGs). Retinoic acid-inducible gene I (RIG-I) is known to recognize viral RNA and induce IFN expression through tripartite motif-containing protein 25 (TRIM25)-mediated ubiquitination of RIG-I caspase activation and recruitment domains (CARDs). We discovered that MERS-CoV N protein suppresses RIG-I-CARD-induced, but not MDA5-CARD-induced, IFN-β and IFN-λ1 promoter activity. By interacting with TRIM25, N protein impedes RIG-I ubiquitination and activation and inhibits the phosphorylation of transcription factors IFN-regulatory factor 3 (IRF3) and NF-κB that are known to be important for IFN gene activation. By employing a recombinant Sindbis virus-EGFP replication system, we showed that viral N protein downregulated the production of not only IFN mRNA but also bioactive IFN proteins. Taken together, MERS-CoV N protein functions as an IFN antagonist. It suppresses RIG-I-induced type I and type III IFN production by interfering with TRIM25-mediated RIG-I ubiquitination. Our study sheds light on the pathogenic mechanism of how MERS-CoV causes disease.IMPORTANCE MERS-CoV causes death of about 35% of patients. Published studies showed that some coronaviruses are capable of suppressing interferon (IFN) expression in the early phase of infection and MERS-CoV proteins can modulate host immune response. In this study, we demonstrated that MERS-CoV nucleocapsid (N) protein suppresses the production of both type I and type III IFNs via sequestering TRIM25, an E3 ubiquitin ligase that is essential for activating the RIG-I signaling pathway. Ectopic expression of TRIM25 rescues the suppressive effect of the N protein. In addition, the C-terminal domain of the viral N protein plays a pivotal role in the suppression of IFN-β promoter activity. Our findings reveal how MERS-CoV evades innate immunity and provide insights into the interplay between host immune response and viral pathogenicity.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  MERS-CoV; RIG-I; TRIM25; interferon-β; interferon-λ1; nucleocapsid protein

Mesh:

Substances:

Year:  2020        PMID: 32295922      PMCID: PMC7307178          DOI: 10.1128/JVI.00099-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.

Authors:  Taro Kawai; Shintaro Sato; Ken J Ishii; Cevayir Coban; Hiroaki Hemmi; Masahiro Yamamoto; Kenta Terai; Michiyuki Matsuda; Jun-ichiro Inoue; Satoshi Uematsu; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2004-09-07       Impact factor: 25.606

2.  The role of transposable elements in the regulation of IFN-lambda1 gene expression.

Authors:  Scott J P Thomson; Fui G Goh; Helen Banks; Thomas Krausgruber; Sergei V Kotenko; Brian M J Foxwell; Irina A Udalova
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

3.  Hepatitis C Virus NS3 Protein Plays a Dual Role in WRN-Mediated Repair of Nonhomologous End Joining.

Authors:  Tsu-I Chen; Yuan-Kai Hsu; Chia-Yi Chou; Yu-Hsin Chen; Shing-Tzu Hsu; Yan-Shuo Liou; Yu-Ching Dai; Ming-Fu Chang; Shin C Chang
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

4.  Identification of CDK4 as a target of c-MYC.

Authors:  H Hermeking; C Rago; M Schuhmacher; Q Li; J F Barrett; A J Obaya; B C O'Connell; M K Mateyak; W Tam; F Kohlhuber; C V Dang; J M Sedivy; D Eick; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

5.  Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists.

Authors:  Sarah A Kopecky-Bromberg; Luis Martínez-Sobrido; Matthew Frieman; Ralph A Baric; Peter Palese
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

6.  Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7.

Authors:  M Sato; N Hata; M Asagiri; T Nakaya; T Taniguchi; N Tanaka
Journal:  FEBS Lett       Date:  1998-12-11       Impact factor: 4.124

7.  TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.

Authors:  Michaela U Gack; Young C Shin; Chul-Hyun Joo; Tomohiko Urano; Chengyu Liang; Lijun Sun; Osamu Takeuchi; Shizuo Akira; Zhijian Chen; Satoshi Inoue; Jae U Jung
Journal:  Nature       Date:  2007-04-19       Impact factor: 49.962

8.  IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes.

Authors:  Pamela I Osterlund; Taija E Pietilä; Ville Veckman; Sergei V Kotenko; Ilkka Julkunen
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

9.  Porcine epidemic diarrhea virus nucleocapsid protein antagonizes beta interferon production by sequestering the interaction between IRF3 and TBK1.

Authors:  Zhen Ding; Liurong Fang; Huiyuan Jing; Songlin Zeng; Dang Wang; Lianzeng Liu; Huan Zhang; Rui Luo; Huanchun Chen; Shaobo Xiao
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

10.  MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection.

Authors:  Javier Canton; Anthony R Fehr; Raúl Fernandez-Delgado; Francisco J Gutierrez-Alvarez; Maria T Sanchez-Aparicio; Adolfo García-Sastre; Stanley Perlman; Luis Enjuanes; Isabel Sola
Journal:  PLoS Pathog       Date:  2018-01-25       Impact factor: 6.823

View more
  22 in total

1.  Coronaviruses exploit a host cysteine-aspartic protease for replication.

Authors:  Hin Chu; Yuxin Hou; Dong Yang; Lei Wen; Huiping Shuai; Chaemin Yoon; Jialu Shi; Yue Chai; Terrence Tsz-Tai Yuen; Bingjie Hu; Cun Li; Xiaoyu Zhao; Yixin Wang; Xiner Huang; Kin Shing Lee; Cuiting Luo; Jian-Piao Cai; Vincent Kwok-Man Poon; Chris Chung-Sing Chan; Anna Jinxia Zhang; Shuofeng Yuan; Ko-Yung Sit; Dominic Chi-Chung Foo; Wing-Kuk Au; Kenneth Kak-Yuen Wong; Jie Zhou; Kin-Hang Kok; Dong-Yan Jin; Jasper Fuk-Woo Chan; Kwok-Yung Yuen
Journal:  Nature       Date:  2022-08-03       Impact factor: 69.504

2.  SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.

Authors:  Hainan Liu; Yu Bai; Xun Zhang; Ting Gao; Yue Liu; Entao Li; Xuefeng Wang; Zheng Cao; Lin Zhu; Qincai Dong; Yong Hu; Guangfei Wang; Caiwei Song; Xiayang Niu; Tong Zheng; Di Wang; Zijing Liu; Yanwen Jin; Ping Li; Xiuwu Bian; Cheng Cao; Xuan Liu
Journal:  J Virol       Date:  2022-06-02       Impact factor: 6.549

3.  Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient.

Authors:  Maria D I Manunta; Giuseppe Lamorte; Francesca Ferrari; Elena Trombetta; Mario Tirone; Cristiana Bianco; Alessandra Cattaneo; Luigi Santoro; Guido Baselli; Manuela Brasca; Mahnoosh Ostadreza; Elisa Erba; Andrea Gori; Alessandra Bandera; Laura Porretti; Luca V C Valenti; Daniele Prati
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

4.  Interferon-α-2b aerosol inhalation is associated with improved clinical outcomes in patients with coronavirus disease-2019.

Authors:  Jiong Yu; Xuan Lu; Ling Tong; Xiaowei Shi; Jing Ma; Feifei Lv; Jian Wu; Qiaoling Pan; Jinfeng Yang; Hongcui Cao; Lanjuan Li
Journal:  Br J Clin Pharmacol       Date:  2021-05-24       Impact factor: 3.716

Review 5.  The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.

Authors:  Nicholas A Wong; Milton H Saier
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 6.208

Review 6.  TRIM Proteins in Host Defense and Viral Pathogenesis.

Authors:  Maria I Giraldo; Adam Hage; Sarah van Tol; Ricardo Rajsbaum
Journal:  Curr Clin Microbiol Rep       Date:  2020-08-08

Review 7.  The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.

Authors:  Zahra Asadzadeh; Noora Karim Ahangar; Hajar Alemohammad; Basira Najafzadeh; Nima Hemmat; Afshin Derakhshani; Amir Baghbanzadeh; Hossein Bannazadeh Baghi; Darya Javadrashid; Souzan Najafi; Meriadeg Ar Gouilh; Behzad Baradaran
Journal:  Arch Virol       Date:  2021-01-18       Impact factor: 2.685

Review 8.  Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.

Authors:  Thomas Kehrer; Adolfo García-Sastre; Lisa Miorin
Journal:  J Interferon Cytokine Res       Date:  2021-06       Impact factor: 3.657

Review 9.  Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity.

Authors:  Andrea Picchianti Diamanti; Maria Manuela Rosado; Claudio Pioli; Giorgio Sesti; Bruno Laganà
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

10.  SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.

Authors:  Soo Jin Oh; Ok Sarah Shin
Journal:  Cells       Date:  2021-03-02       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.